Aelion J - Search Results

1

Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study.

Östör A, Van den Bosch F, Papp K, Asnal C, Blanco R, Aelion J, Lu W, Wang Z, Soliman AM, Eldred A, Padilla B, Kivitz A. Östör A, et al. Among authors: aelion j. Rheumatology (Oxford). 2023 Jun 1;62(6):2122-2129. doi: 10.1093/rheumatology/keac605. Rheumatology (Oxford). 2023. PMID: 36282537 Free PMC article. Clinical Trial.

2

Preservation of the specificity of superantigen to T cell receptor V beta elements in the absence of MHC class II molecules.

Kotb M, Watanabe-Ohnishi R, Aelion J, Tanaka T, Geller AM, Ohnishi H. Kotb M, et al. Among authors: aelion j. Cell Immunol. 1993 Dec;152(2):348-57. doi: 10.1006/cimm.1993.1296. Cell Immunol. 1993. PMID: 8258143

3

Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis.

Leung DY, Travers JB, Giorno R, Norris DA, Skinner R, Aelion J, Kazemi LV, Kim MH, Trumble AE, Kotb M, et al. Leung DY, et al. Among authors: aelion j. J Clin Invest. 1995 Nov;96(5):2106-12. doi: 10.1172/JCI118263. J Clin Invest. 1995. PMID: 7593594 Free PMC article.

4

Treatment of calcinosis with diltiazem.

Palmieri GM, Sebes JI, Aelion JA, Moinuddin M, Ray MW, Wood GC, Leventhal MR. Palmieri GM, et al. Among authors: aelion ja. Arthritis Rheum. 1995 Nov;38(11):1646-54. doi: 10.1002/art.1780381117. Arthritis Rheum. 1995. PMID: 7488286

5

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

Khanna D, Lin CJF, Furst DE, Goldin J, Kim G, Kuwana M, Allanore Y, Matucci-Cerinic M, Distler O, Shima Y, van Laar JM, Spotswood H, Wagner B, Siegel J, Jahreis A, Denton CP; focuSSced investigators. Khanna D, et al. Lancet Respir Med. 2020 Oct;8(10):963-974. doi: 10.1016/S2213-2600(20)30318-0. Epub 2020 Aug 28. Lancet Respir Med. 2020. PMID: 32866440 Clinical Trial.

6

Role of the conserved histidine and aspartic acid residues in activity and stabilization of human gelatinase B: an example of matrix metalloproteinases.

Pourmotabbed T, Aelion JA, Tyrrell D, Hasty KA, Bu CH, Mainardi CL. Pourmotabbed T, et al. Among authors: aelion ja. J Protein Chem. 1995 Oct;14(7):527-35. doi: 10.1007/BF01886879. J Protein Chem. 1995. PMID: 8561849

7

Extraosseous uptake of Tc-99m HDP in muscular dystrophy.

Nye PJ, Aelion JA, Odhav SK, Bain S. Nye PJ, et al. Among authors: aelion ja. Clin Nucl Med. 2000 Feb;25(2):135-6. doi: 10.1097/00003072-200002000-00013. Clin Nucl Med. 2000. PMID: 10656652 No abstract available.

8

Characterization of unique human TCR V beta specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein.

Watanabe-Ohnishi R, Aelion J, LeGros L, Tomai MA, Sokurenko EV, Newton D, Takahara J, Irino S, Rashed S, Kotb M. Watanabe-Ohnishi R, et al. Among authors: aelion j. J Immunol. 1994 Feb 15;152(4):2066-73. J Immunol. 1994. PMID: 8120408

9

Myopathy in sarcoidosis: clinical and pathologic study of four cases and review of the literature.

Wolfe SM, Pinals RS, Aelion JA, Goodman RE. Wolfe SM, et al. Among authors: aelion ja. Semin Arthritis Rheum. 1987 May;16(4):300-6. doi: 10.1016/0049-0172(87)90008-4. Semin Arthritis Rheum. 1987. PMID: 3299715 Review.

10

Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study.

Sieper J, Deodhar A, Marzo-Ortega H, Aelion JA, Blanco R, Jui-Cheng T, Andersson M, Porter B, Richards HB; MEASURE 2 Study Group. Sieper J, et al. Among authors: aelion ja. Ann Rheum Dis. 2017 Mar;76(3):571-592. doi: 10.1136/annrheumdis-2016-210023. Epub 2016 Aug 31. Ann Rheum Dis. 2017. PMID: 27582421 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page